Clinical management of autosomal dominant polycystic kidney disease.
Autosomal dominant polycystic kidney disease (ADPKD) is a common systemic genetic disease which comprises 8 to 10% of patients treated by dialysis and transplantation. Breakthroughs in molecular genetics and cell biology have led to new insights into cyst formation and growth. Until the specific genetic defects are identified, the management of this disorder will necessarily be empiric. This paper discusses current management strategies in ADPKD focusing on hypertension, hematuria, pain and infection. Special considerations for management of end-stage renal failure in patients with ADPKD are also reviewed.
Bennett
W M
WM
Division of Nephrology and Hypertension, Oregon Health Sciences University, Portland.
Elzinga
L W
LW
D006417:Hematuria / Q000209:etiology / Q000628:therapy; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology / Q000628:therapy; D007239:Infections / Q000150:complications / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy; D010146:Pain / Q000209:etiology; D059408:Pain Management; D016891:Polycystic Kidney, Autosomal Dominant / Q000150:complications / Q000628:therapy*